Stanley J. Meresman - Feb 10, 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John Saia, as attorney-in-fact for Stanley J Meresman
Stock symbol
GH
Transactions as of
Feb 10, 2022
Transactions value $
-$364,129
Form type
4
Date filed
2/14/2022, 03:27 PM
Previous filing
Jan 12, 2022
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $29.3K +4.93K +121.56% $5.94 8.99K Feb 10, 2022 Direct
transaction GH COMMON STOCK Sale -$364K -4.93K -54.86% $73.80 4.06K Feb 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH STOCK OPTION (RIGHT TO BUY) Options Exercise -$29.3K -4.93K -25% $5.94 14.8K Feb 10, 2022 COMMON STOCK 4.93K $5.94 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018.